Ono Pharma Breakthrough Science Initiative Award: Harvard Pre-Proposal Deadline

Ono Pharma Breakthrough Science Initiative AwardHarvard Pre-Proposal Deadline: January 3, 2023
Sponsor LOI Deadline (if nominated): February 15, 2023
Award Amount: $300,000/year for up to 3 years and a maximum of an additional 15% ($45,000) per year for indirect costs

The Breakthrough Science Initiative Awards Program accepts proposals from Principal Investigators involved in original research of Chemical Biology. Chemical Biology is defined as research that deals with the interface between chemistry and biology. The criteria for this field are deliberately broad so as not to disqualify potentially innovative and groundbreaking projects. The goals of the Ono Initiative are to identify and develop innovative research proposals and results that could lead to the development of breakthrough treatment solutions for patients; support academic research and the career development of promising young and established scientists; and build strong relationships within the community in order to lead to transformative research aligned with Ono Initiative's interest.

To be eligible, the PI must be a junior or mid-career scientist (within 15 years of starting an independent academic position). Parental leave will be considered in calculating eligibility. The PI must be a new applicant to the Ono Initiative, or, if they are returning, have applied over three years ago for a project different from the one they are currently proposing. The PI may not already be engaged in other sponsored research with Ono Pharmaceutical Co., Ltd. and/or other grant programs with the Ono Pharma Foundation. The PI may not apply for funding to amplify current work. However, PIs may research a new idea based on a prior finding.

Recent recipients include Jarad Mason (2022, CCB), Brian Liau (2019, CCB) and Christina Woo (2018, CCB).

This is a limited submission opportunity and Harvard University may submit only two proposals. The Office of the Vice Provost for Research is facilitating an internal selection process for eligible applicants. Applicants must submit a pre-proposal to the internal competition via the link above no later than January 3, 2023. Ono Pharmaceutical will accept separate nominations from The Broad Institute of MIT and Harvard, and Beth Israel Deaconess Medical Center. Applicants from these institutions should not apply through the OVPR facilitated process.